Frontlight ResearchEarly access
Trial site
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Follicular lymphoma1 trial
- Hepatitis B1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Celgene2 trials
- Janssen Research & Development, LLC2 trials
- Alfasigma S.p.A.1 trial
- Kowa Research Institute, Inc.1 trial
- Nanjing IASO Biotechnology Co., Ltd.1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Follicular lymphoma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026